The potential of micro- and nanorobots in biomedical applications has drawn significant interest. These devices are modeled after natural organisms such as bacteria and sperm cells. By utilizing the propulsion mechanisms of motile sperm and other microorganisms, these biohybrid systems offer innovative approaches for drug delivery, assisted reproduction, and disease therapy in fluidic environments. Despite advancements, replicating the intricate architecture and functions of natural sperm cells at the nanoscale remains challenging, particularly regarding size homogeneity, flexibility, and propulsion efficiency. Recent efforts have focused on developing artificial sperm-like nanorobots with enhanced motility using techniques such as electrospinning, 3D printing, and magnetic assembly. These spermbots demonstrate the ability to transport targeted payloads, navigate through biofluids, and potentially address male infertility. Furthermore, integrating external control systems- such as magnetic fields and chemical stimuli-enables precise regulation of spermbot movement and function. Although clinical translation is still in its early stages, preclinical studies have highlighted the promise of spermbots in targeted drug delivery, tumor therapy, and reproductive medicine. However, challenges related to biocompatibility, biodegradability, and ethical considerations- particularly regarding their application in human reproduction-must be addressed before these systems can be widely adopted in therapeutic settings.
Saikia et al. (Wed,) studied this question.